Improving Patient Reported Outcome Measures in Catheter Ablation
NCT04499326
Summary
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD). It is designed to have feasibility outcomes which contribute to answering the above.
Eligibility
Inclusion Criteria: Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD. And impaired LV/RV function Willing and able to give written informed consent Exclusion Criteria: Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04499326